Skip to main content
Log in

Comparison of the antimuscarinic activity of mianserin and amitriptyline in the cat superior cervical ganglion

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The antimuscarinic activity of mianserin and amitriptyline was investigated in the cat superior cervical ganglion using McN-A-343 as a muscarinic agonist. Mianserin was found to have a similar order of potency to amitriptyline in this preparation, in contrast to the marked difference in their antimuscarinic activities on non-neuronal muscarinic receptors.

These findings suggest that the action of mianserin on neuronal muscarinic receptors is more important than that predicted from studies on non-neuronal receptors and may be related to its anti-depressant activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Brogden RN, Heel RC, Speight TM, Avery GS (1978) Mianserin: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 16:273–301

    Google Scholar 

  • Brown DA, Caulfield MP (1979) Hyperpolarizing 'α'-adrenoceptors in rat sympathetic ganglia. Br J Pharmacol 68:435–445

    Google Scholar 

  • Browne RG (1979) Effects of antidepressants and anticholinergics in a mouse “behavioural despair” test. Eur J Pharmacol 58:331–334

    Google Scholar 

  • Cairncross KD, McCulloch MW, Story DF, Trinker F (1967) Modification of synaptic transmission in the superior cervical ganglion by epinephrine, norepinephrine and nortriptyline. Int J Neuropharmacol 6:293–300

    Google Scholar 

  • Cavero I, Lefevre-Borg F, Roach AG (1980) Comparison of mianserin with desipramine and maprotiline on blood pressure responses to acetylcholine, histamine and 5-hydroxytryptamine in normotensive rats. Br J Pharmac 69:342P-343P

    Google Scholar 

  • Chen G, Portman R, Wickel A (1951) Pharmacology of 1,1-dimethyl-4-phenyl-piperazinium iodide, a ganglion stimulating agent. J Pharmacol Exp Ther 103:330–336

    Google Scholar 

  • De Groat WC, Volle RL (1963) Ganglionic actions of oxotremorine. Life Sci 2:618–623

    Google Scholar 

  • De Groat WC, Volle RL (1966) The actions of catecholamines on transmission in cat superior cervical ganglion. J Pharmacol Exp Ther 154:1–13

    Google Scholar 

  • Doggrell SA (1979) Mianserin potentiates responses to acetylcholine in the rat anococcygeus muscle. Eur J Pharmacol 55:311–314

    Google Scholar 

  • Doxey JC, Everitt JE, Metcalf G (1978) Mianserin — An analysis of its peripheral autonomic actions. Eur J Pharmacol 51:1–10

    Google Scholar 

  • Fisher A, Weinstock M, Gritter S, Cohen S (1976a) A new probe for heterogeneity in muscarinic receptors: 2-methyl-spiro-(1,3-dioxolane-4,3′)-quinuclidine. Eur J. Pharmacol 37:329–338

    Google Scholar 

  • Fisher A, Grunfield Y, Weinstock M, Gritter S, Cohen S (1976b) A study of muscarinic receptor heterogeneity with weak antagonists. Eur J Pharmacol 38:131–139

    Google Scholar 

  • Frankhuyzen AL, Bonta IL (1974) Effect of mianserin, a potent antiserotonin agent, on the isolated rat stomach fundus preparation. Eur J Pharmacol 25:40–50

    Google Scholar 

  • Haefely W (1974) The effects of 5-hydroxytryptamine and some related compounds on the cat superior cervical ganglion in situ. Naunyn-Schmiedeberg's Arch Pharmacol 281:145–165

    Google Scholar 

  • Janowsky DS, Davis JM, El-Yousef MK, Sekerke HJ (1972) A cholinergic-adrenergic hypothesis of mania and depression. Lancet 2:632–635

    Google Scholar 

  • Jaramillo J, Volle RL (1967) Nonmuscarinic stimulation and block of a sympathetic ganglion by 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343). J Pharmacol Exp Ther 157:337–345

    Google Scholar 

  • Jones A (1963) Ganglionic actions of muscarinic substances. J Pharmacol Exp Ther 141:195–205

    Google Scholar 

  • Kadzielawa K, Giawecka I, Kadzielawa R (1968) The potentiating influence of imipramine on ganglionic effects of catecholamines. Int J Neuropharmacol 7:517–521

    Google Scholar 

  • Kopera H (1978) Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo. Br J Clin Pharmacol 5:29S-35S

    Google Scholar 

  • Murayama S, Unna KR (1963) Stimulant action of 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343) on sympathetic ganglia. J Pharmacol Exp Ther 140:183–192

    Google Scholar 

  • Pinder RM, Brogden RN, Speight TM, Avery GS (1973) Viloxazine: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 13:401–421

    Google Scholar 

  • Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379–391

    Google Scholar 

  • Puech AJ, Frances H, Souto M, Chermat R, Simon P (1979) Problems of pharmacological screening for antidepressants. In: Dumont C (ed) Advances in pharmacology and therapeutics. Proc 7th Int Congress of Pharmacol, Paris 1978, vol 5. Neuropsychopharmacol Pergamon Press, Oxford p 171

    Google Scholar 

  • Randrup A, Braestrup C (1977) Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression. Psychopharmacology 53:309–314

    Google Scholar 

  • Robson RD, Antonaccio MJ, Saelens JK, Liebman J (1978) Antagonism by mianserin and classical α-adrenoceptor blocking drugs of some cardiovascular and behavioural effects of clonidine. Eur J Pharmacol 47:431–442

    Google Scholar 

  • Saxena PR, van Houwelingen P, Bonta IL (1971) The effects of mianserin hydrochloride on the vascular responses evoked by 5-hydroxytryptamine and related vasoactive substances. Eur J Pharmacol 13:295–305

    Google Scholar 

  • Smith JC (1966) Pharmacologic interactions with 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride, a sympathetic ganglion stimulant. J Pharmacol Exp Ther 153:276–284

    Google Scholar 

  • Takeshige C, Volle RL (1964) Similarities in the ganglionic actions of calcium ions and atropine. J Pharmacol Exp Ther 145:173–180

    Google Scholar 

  • Vargaftig BB, Coignet JL, de Vos CJ, Grijsen H, Bonta IL (1971) Mianserin hydrochloride: peripheral and central effects in relation to antagonism against 5-hydroxytryptamine and tryptamine. Eur J Pharmacol 16:336–346

    Google Scholar 

  • Wallis DI (1979) The apparent multiplicity of ganglionic receptors. In: Kalsner S (ed) Trends in autonomic pharmacology, vol 1, Urban & Schwarzenberg, Inc., Baltimore Munich, p 21

    Google Scholar 

  • Wamsley JK, Black AC Jr, Redick JA, West JR, Williams TH (1978) SIF cells, cyclic AMP responses and catecholamines of the guinea pig superior cervical ganglion. Brain Res 156:75–82

    Google Scholar 

  • Weinstock M, Cohen D (1976) Tricyclic antidepressant drugs as antagonists of muscarinic receptors in sympathetic ganglia. Eur J Pharmacol 40:321–328

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kwok, Y.H., Mitchelson, F. Comparison of the antimuscarinic activity of mianserin and amitriptyline in the cat superior cervical ganglion. Naunyn-Schmiedeberg's Arch. Pharmacol. 316, 161–164 (1981). https://doi.org/10.1007/BF00505311

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00505311

Key words

Navigation